First Immune GcMAF

treatment for cancer, aids and immune diseases

  • Increase font size
  • Default font size
  • Decrease font size
Home Who are we?

Who are we?

We are PhD and BSc biochemists and biomedical scientists, with David Noakes as the contact person (who has a track record in public life) with external doctors, oncologists and scientists who kindly provide advice, committed to bringing some of the increasing number of published but relatively unused medical cures to as many people as we can.

We are interested in the eradication of disease, initially cancer, that can be proven at the molecular biology level.

We wish you well in every sense of the expression.

 

This is what we believe:

At the top are billion dollar pharmaceutical companies charging around $360,000 to kill a person with the poison of chemotherapy. And in five years, they kill 97%. That's murder for profit.

Put "Chemo kills" into a search engine, and you'll find hundreds of doctors and scientists who say its not cancer, but chemotherapy, that is the main killer of cancer patients.

The FDA protects their monopoly, and keeps effective new medicine out with an $800 million entry fee. That's corruption.

There have been 6 attempts to close us down, one by a pharmaceutical successful for 9 months in 2010. Our scientists have been subjected to some of that personally, which is why David is the only name to appear on the website.

At the bottom there are companies selling untested substances as GcMAF and making false claims. That's at least unethical if it isn't fraud, and it sullies the reputation of GcMAF.

We were advised not to speak out when we knew two companies were selling inactive GcMAF. A small number of people died of cancer who need not have. One company closed, the other is still going.

Unfortunately the pharmaceutical world, top to bottom, is as corrupt at the political world. "For evil to triumph, all that is required is for good men to do nothing."   So we have spoken out, a little, now.



Our methods and aims

We have spent three years ensuring we work to the highest possible ethical standards with our own highly professional biomedical scientists. We have the best of laboratories which we own ourselves.

We have always performed a minimum of 5 tests, as it says in "Tests of our GcMAF" on the left hand side of our GcMAF.eu website.

One of our tests has always been sterility - by the Government's Health Protection Agency, the top authority.  From day one.

You are probably aware our GcMAF has always, right from the first batch, been tested with live cancer cell and or macrophage assays, the only way you can tell if it is active.

Professor Ruggiero's team did 270 experiments at the University of Florence with our GcMAF in 2011 and wrote 8 major research papers, and kindly credited us for supplying the GcMAF.

No GcMAF in the world has ever been tested to so exacting a degree.

So our GcMAF has been independently tested, by the top GcMAF team in the world.

Now we are the only supplier to have that capability in house too.

You cannot prove GcMAF is active unless you carry out live cell tests.

We now put our batches of GcMAF through 6 tests in our laboratory.

The penultimate is to add macrophages to the MCF7 cancer cell line in vitro. Nothing happens. Then we add the GcMAF. In 72 hours the cancer cells have been eaten by the macrophages.

The last is to add GcMAF to the cancer cells without macrophages. In 72 hours the GcMAF has reverted the cancer cells back into healthy cells.

This is futuristic research to most of the world's pharmaceuticals.  To us, its everyday production.

Only two publicly available GcMAFs can therefore prove they are GcMAF - ours, and Jim Tassano's from California.

Our PhD's and BSc's work with other scientists in the field who are keen to use our lab, because it gives them all the facilities they need.

We are compelled to be the best and to do it right, because that is how our minds force us to work. So we have no choice than to remain committed to the highest standards that are possible with the resources available.

David Noakes

 

link